particles with a ±10 Au atom variation. (Lund et. al., 2011) [2] (Figure 2 ). The term nanoparticle (NP) is often used to describe these structures, but this does not necessary give a correct perception of a nanoparticle. These structures can also be considered as scaffolds formed of atoms used to build advance structures; for example 57 atoms of Au can be used as a scaffold on which further atoms can be attached followed by the addition of biological ligands. Nanoparticles can also be created using different composite materials at the Nanoscale, changing their physical properties. Importantly these properties do not generally coincide with larger non-nanoscale counterparts.
Size also affects the NP physical properties so it is important to create particles with consistent structures that can be reproduced. The material used in the fabrication of the nanoparticle can include gold, iron, silver, cerium, titanium dioxide, silica, carbon, zinc, copper, nickel, magnesium and composites thereof. Gold is favoured in the construction of nanoparticles as it is hydrophobic although normally gold is paramagnetic which can cause issues when they are used as contrast agents. The very first report of a water-soluble gold nanoparticle was 2001 by de la Fuente JM et. al., [3] . Composite have been produced for example gold and gold-iron oxide magnetic glyconanoparticles to combine the advantage of gold and magnetics properties. (de la Fuente el al 2006) [4] The balance between the nanoparticle physical properties, their biocompatibility and the evidence that there are no cytotoxic effects is key to their successful use in clinical applications. Another important feature is the configuration of the ligands and their interaction with the atoms on the particle surface as they play a significant role in determining the physiochemical properties of the NPs and therefore their interaction with the human body and biological material.
It is also worth noting that extensive efforts have been made to synthesize and characterize nanoparticles at sizes smaller than 6nm, which includes the core and attached ligands (Figure 1 ), as this is the maximum size that will pass through the kidney. This is size, charge and shape-dependent due to the unique structure of the glomerular capillary wall. A globular AuNP with a hydrodynamic diameter (HD) < 6 nm can pass through the glomerular capillary wall easily, while it is difficult for a large one (HD > 8 nm) to cross through due to the kidney filtration threshold (KFT) which is about 5.5 nm. Furthermore, the surface charges of a NP also play an important role in the kidney filtration: a positively charged NP with an HD (6-8 nm) slightly larger than KFT can pass the kidney filtration barrier due to the favourable charge interactions with the glomerular capillary wall which is negatively charged, whereas filtration through the kidney is difficult for the negatively charged or neutral NP with an HD of 6-8 nm. (Kumara et al 2014) [1] provides an illustration demonstrated the size range of nanomolecules to nanoparticles and Faradaurates. The range of uses of different types of NPs are difficult to fully categorise, but this review will mainly focus on two specific areas, therapy and diagnosis. NPs can deliver therapy by a number of methods: by enhancement of radiotherapy or heating to cause cell death, as a scaffold to construct new molecular structures to help target or deliver drugs, and as an image contrast agent to identify disease conditions. This review gives a brief overview of some of these areas.
2 Diagnostics: Imaging and point of care technologies are two specific areas that could benefit from the application of NPs.
Imaging:
In the case of imaging, a contrast agent that could associate with tumours through bonding of the NP surface ligands to the cancer biomarker would be of significant use in tracking the application of diagnoses and therapy. However, identification of appropriate ligands that bind to the cancer biomarker is still a key challenge. Contrast agents are often used to track particular physiological process during imaging and NPs can play a major role in the future of medical diagnostics due to their many advantages over the conventional contrast agents, such as controlled biological clearance pathways, specific molecular targeting capabilities (Shilo et al, 2012 ) [5] and prolonged blood circulation time, providing a longer time for imaging. This offers an advantage over contrast agents made from particles larger than 1 μm, which are cleared rapidly by the body's reticuloendothelial system following injection into the bloodstream.
MRI:
The application of nanotechnology to the field of medical imaging offers a number of advantages. In the case of MRI, iron-based NPs causes a change in the magnetic field but gold-based NPs are non-paramagnetic and although they are biological compatible, do not affect the contrast of the tissues or blood. MRI contrast agents require the proton relaxation to be altered and must be able to perturb the local magnetic field around the proton. The perturbing field in MRI of a super paramagnetic particle is effective at up to 50-times its diameter, and therefore influences water protons in several cell layers around its location (Shilo et. al dispersed in agarose at 1-2.5% mass concentration can be imaged by a highresolution ultrasound imaging system (transducer centre frequency: 30 MHz). They also investigated polystyrene particles of different sizes (500-3000 nm) and concentrations (0.13-0.75% mass), which were similarly dispersed in agarose and imaged. (Liu et. al., 2006 ) [9] .
The potential use of platinum nanoparticles (Pt-NPs), as a superoxide dismutase (SOD)/catalase mimetic antioxidant, has been studied by Jawaid, P., et. al., [10] The Pt-NPs in combination with 1MHz ultrasound at an intensity of 0.4 W/cm(2), 10% duty factor, 100 Hz PRF, for 2 min promoted apoptosis in human myelomonocytic lymphoma U937 cells assessed by DNA fragmentation assay, cell cycle analysis and Annexin V-FITC/PI staining. Cell counting and microscopic examination confirmed cell death. The mitochondrial and Ca(2+)-dependent pathways were also investigated.
These studies addressed the issue of the mechanisms of cell death following therapeutic ultrasound treatment in the presence or absence of Pt-NPs. The important conclusion was that Pt-NPs appeared to interfere with apoptosis and consequently block ultrasound-induced autophagy, this paradoxically led to increased cell killing.
The authors concluded that autophagy induced after ultrasound mechanical effects operates "pro-survival pathway" and its blockade by Pt-NPs causes enhancement of cell killing. [13] recently investigated methods to differentiate between cancer and inflammation during functional computed tomography since PET scanning using 18 F glucose is unable to distinguish between an inflammatory lesion and a cancer lesion as both have increased glucose metabolic associated uptake. They found that glucose AuNPs can act as a CT agent and which allows for the differentiation between cancer and an inflammatory process.
CT:
Although new research papers are continuously being published in this area the key challenge is the acceptance of their use in humans, which requires more studies on the long-term effect of the NPs.
Point-of-Care:
A promising area in diagnostics is the development of point-ofcare biosensor devices. Point-of-Care devices for a range of diagnoses is an expanding research field particularly where there is a need for high specificity and sensitivity.
AuNPs can be used to enhance this for a range of applications for example in an electrical biosensor they can be applied to the surface to effectively increase the surface area of the sensor and so increase the sensitivity. There are a number of groups developing these with AuNPs. These include detection of human phospholipase A2 in pancreatitis, aggregation and self-association of monoclonal antibodies (Li et. al., 2013) [14] , milk contamination using alkaline phosphatase (Yu et. al., 2015) [15] and anti-tumour antibodies for the diagnosis of prostate cancer (Zheng et. al., 2014) [16] .
Therapy:
The use of NPs for therapy is probably the most important area of development in NP research. The ability to enhance or improve the delivery of target therapy is considerable and some of the most promising findings are detailed below: Radiation therapy along with surgery and chemotherapy are the major therapeutic strategies for cancer treatment. Unfortunately the development of resistance to the therapeutic modality is a major reason for the absence of cure and subsequent tumor growth. It requires the delivery of high intensity ionizing radiations with high accuracy to the tumor tissue resulting in the death of tumor cells. Radiation therapy has its disadvantages including the possibility of injury to the surrounding normal tissue. Another disadvantage is that some tumor cells are farther away from the site of radiation and hence might receive a lower intensity of the radiation beam. Moreover, the cells can develop resistance to the radiation. Usually the sensitivity of the mitotically active tumor cells is only slightly higher than that of surrounding healthy tissue so that the minimum dose of radiation that is sufficient to kill tumor tissue may only injure but not kill the normal tissue. However, due to development of resistance of tumor cells to the dosed radiation results in the requirement of elevated doses which eventually leads to death of the healthy tissue.
Multiple approaches have been utilized to limit the radiation resistance while simultaneously enhancing the efficacy and safety of radiation therapy. The three major approaches for the improvement of radiation therapy have involved (a) enhancing radiosensitization of tumor tissue; (b) reversing of radiation resistance in tumor tissue; and (c) enhancing radio resistance of the healthy tissue. (Kwatra et. al., 2013) [19] . As with all forms of cancer treatment the aim of radiotherapy is to selectively maximise tumour killing while reducing the damage to healthy tissue. The first demonstration of AuNPs was present by Hainfeld et. al., (2004) [20] . AuNP radio enhancement has become an increasing area of investigation as an approach to increase the effectiveness of ionising radiation in biological systems. The biocompatibility is ideal although there is much work still required to improve the targeting of AuNPs at tumor sites to make it an ideal therapeutic contrast agent. Au's radiosensitization is due to its increased photoelectric absorption cross section in comparison to that of the surrounding cells. During irradiation, this results in an enhancement of the energy deposition in the vicinity of the gold particles due to the generation of photoelectrons, Auger electrons, and characteristic X-rays.
Recently, McQuaid et.al., (2016) [21] presented the first experimental results that take into account both the measured biodistribution of gold nanoparticles at the cellular level and the range of the product electrons responsible for energy deposition.
Combining synchrotron-generated monoenergetic X-rays, intracellular gold particle imaging and DNA damage assays, enabled a DNA damage model to be generated that includes the production of intermediate electrons. This is an important result as it is the first time good agreement between the predictions of biological outcomes from [23] estimated the optimal size for simultaneously enhanced CT imaging and radiotherapy. They used the Enhanced Permeability and Retention (EPR) effect to get the larger particles trapped in the stroma around the tumour. Particles were investigated in the range of 3-50nm and they concluded that 13nm particles were the optimum for the dual application.
A number of investigators have studied the use of AuNPs for specific cancers. Indeed, Ma et. al., 2016 [37] showed that the activity of a humanized mouse monoclonal that had been developed to treat hepatocellular carcinoma could be enhanced by conjugation to AuNP. Another approach is the use of AuNP nanoseeds for non-resectable solid tumour treatment (Moeendarbari et al., 2016 [38] ). These constructs consist of AuNPs passivated with palladium -103. There appear to be many reports highlighting the use of nanoseeds for brachytherapy Although there is considerable evidence that NPs do have potential for cancer therapy, only very limited human trials of NPs have been reported essentially due to the need for long term studies to ascertain any future toxicity effects on patients and the requirement for FDA approval. 
Wound healing and burns:

Cardiovascular disease:
Restenosis is a major problem in cardiovascular disease. [44] describe the use of immunoresonance scattering to measure the ApoAI and ApoB in serum. A trisodium citrate method was used to prepare 9.0-nm gold nanoparticles labeled with goat anti-human ApoAI and ApoB antibodies. The immune reaction between gold-labeled antibodies and antigens took place in Na2HPO4-NaH2PO4 buffer solution (pH 6.4 for ApoAI and pH 6.0 for ApoB) in the presence of 75 g/L polyethylene glycol (PEG). They used a transmission electron microscope to observe the shape of the gold nanoparticles. The method showed high sensitivity and good selectivity for quantitative determination of ApoAI and ApoB in human serum.
Neuroimmunology:
The development of NPs use in the brain is of considerable interest in advancing the treatment of brain disorders. The limitation of this use has primarily been the difficulty of NPs passing the blood brain barrier (BBB). This is meant to protect the brain from toxic agents, but unfortunately it also significantly hinders the delivery of therapeutics to the brain. A number of strategies have been employed to deliver drugs across this barrier and some of these may do structural damage to the BBB by forcibly opening it to allow the uncontrolled passage of drugs (Jain et. al., 2012 [45] ). Nanobiotechnology-based delivery methods provide the best prospects for achieving this. Some strategies require multifunctional NPs combining controlled passage across the BBB with targeted delivery of the therapeutic cargo to the intended site of action in the brain, although there are currently some limitations and concerns for the potential neurotoxicity of NPs. It has been shown that the size, coating and surface charge of nanoparticles have a crucial impact on the passage of NP's across the BBB and subsequent process of intracellular uptake process (Shilo et. al., 2015 [46] ). Shilo et al. concluded that GNPs of size 70 nm are optimal for the maximum amount of gold within the brain cells, and that 20 nm AuNPs are the optimal size for maximum free surface area. However, for the NP to pass out of the kidney they need to be 5nm or less. Morris et al. (2016) [47] reported results from AuNPs (15nm diameter) to study pathways for the passage of fluid into and out of the brain. They concluded that cerebral vascular basement membranes form the pathways by which fluid passes into and out of the brain but that different basement membrane layers are involved. 
Antibiotics
Toxicity:
It is important to consider the adverse effects such as potential toxicity, which is determined by various factors including particle size, shape and ability to interact with the surrounding tissue. NPs may "overload" phagocytic cells, which causes a defensive fever and reduced body immunity. NPs may be difficult to degrade, leading to accumulation in the organs. NPs may also affect enzymes and protein activities and disturb biological processes in the body due to their high surface area [69] . If improved targeting of the drug to increase the efficacy of the treatment could be achieved then the side effects could also be reduced. For example, when doxorubicin is transported by biodegradable nanoparticles, its cardiac toxicity is greatly reduced (Gu et. al., 2012 ) [70] . Also biodegradable porous silicon NPs (pSiNP) functionalised with cancer cell targeting antibodies can also be loaded with the hydrophobic anti-cancer drug camptothecin (Secret et. al., 2013) [71]
Uptake and intracellular fate of NP constructs: One of the key research areas at
present is uptake of NPs in cancer cells. Huang et. al., (2010) [72] showed that nutrient deprivation or an increase in the requirement of nutrients in tumour cells can promote the uptake of NP from the microenvironment. Like Yang et. al., (Section 3.1) [29] they also used RGDyC to target tumour cells. The conjugates also contained Pt(IV) as the cytotoxic agent. They found the constructs more active than the free drug and were able to show that the increased cytoxicity was due to cell cycle arrest.
This is a very different mechanism of action from that of the free drug. Volsi et.
al.,(2016) [73] have published a paper that demonstrates that if AuNPs are passivated with the polymer inulin there is enhanced delivery of the anti-cancer drug doxorubicin leading to preferential accumulation in tumour cells. Experimentally they also use an attractive cancer/non-cancer cell co-culture model.
A number of other researches have investigated the chemotherapeutic agent doxorubicin and its use with AuNPs for treatment of cancer Dhamecha et. al., (2015) [74] use a green method (involving biological and environmental safety of their production. The main methods for nanoparticle production are chemical and physical approaches that are often costly and potentially harmful to the environment) to make the AuNPs loading these particles with doxorubicin. They showed in some cancer cell lines that NP constructs had greater activity than the free doxorubicin. Chaudhary et.
al., (2015) [75] demonstrated that they could achieve a single synthesis of doxorubicin loaded NPs. Showing that doxorubicin can act as both the passivating agent and also the reducing agent removing the necessity of borohydride in the synthesis, is a rather interesting approach. Interestingly, Curry et. al., (2015) [76] published almost simultaneously an empirical and theoretical paper proposing that doxorubicin could itself be a passivating agent for gold nanoparticles as was actually demonstrated by Chaudhary et. al., (2015) [75] above.
Another key area in the targeting of nanoparticles for drug delivery is the loading on nanosystems by covalent conjugation or non-covalent interactions (Ulbrich et. al., 2016 ) [77] , either with the coating or directly with the metallic surface. [84] showed that Au conjugated with a tumour-homing peptide containing NGR can be targeted to CD13 receptors on tumour vasculature, suggesting that NGR-tagged AuNPs can be used as a platform for tumour endothelial cell targeting and therefore for cancer therapy. Magnetic field hyperthermia can be made more effective by the use of biocompatible super paramagnetic NPs, principally iron. In principle, these particles heat cancerous tissue by creating oscillations that produce heat, although the mechanism is not fully understood. Cancer cells could also be treated with AuNPs, which have the advantage that they are biocompatible and allow a range of ligands to be attached to them. Bulk gold metal is diamagnetic but 2 nm dodecanethiol (thiol) capped gold nanoparticles have been reported to exhibit ferromagnetism. This ferromagnetism is believed to result from spin-orbit coupling between surface-bound thiols and gold surface atoms.
As the gold nanoparticle size decreases and the surface area to volume ratio increases, the likelihood of ferromagnetism increases. AuNPs, nanorods and nanoshells have been radiated with visible laser sources that excite the particles at or near their plasmon resonance frequency, and this mechanism has been well studied ( 7 Summary: The table below demonstrates the wide range of NP applications. They have considerable potential to impact many areas of health and will require many new methods to be developed to measure their effects on body functions..
Nonetheless, there are still many challenges to overcome not least the optimal targeting of cells associated with specific disease conditions. Molecular nanotechnology is a rapidly emerging field that will allow for the precise and purposeful arrangement of matter atom by atom and eventually the building of submicron-scale medical sensors and therapeutic devices. These tools could provide the means to analyze, understand, and precisely control the molecular machinery of the human body, allowing the detection and correction of any undesired structural changes (disease or aging) at the finest level of detail and the earliest possible time.
Possible rejuvenation followed by the indefinite maintenance of an optimal physiologic state, or molecular homeostasis, may ultimately become possible (Wu et. al., 2016) [90] .
Although this review divides diagnostics and therapy combine both sometimes termed Theranostics (A combination of diagnostics and therapy) as illustrated by 
